Literature DB >> 18848945

Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice.

Sang Jun Lee1, Garrett Heinrich, Larisa Fedorova, Qusai Y Al-Share, Kelly J Ledford, Mats A Fernstrom, Marcia F McInerney, Sandra K Erickson, Cara Gatto-Weis, Sonia M Najjar.   

Abstract

BACKGROUND & AIMS: Liver-specific inactivation of carcinoembryonic antigen-related cell adhesion molecule 1 causes hyperinsulinemia and insulin resistance, which result from impaired insulin clearance, in liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice (L-SACC1). These mice also develop steatosis. Because hepatic fat accumulation precedes hepatitis, lipid peroxidation, and apoptosis in the pathogenesis of nonalcoholic steatohepatitis (NASH), we investigated whether a high-fat diet, by causing inflammation, is sufficient to induce hepatitis and other features of NASH in L-SACC1 mice.
METHODS: L-SACC1 and wild-type mice were placed on a high-fat diet for 3 months, then several biochemical and histologic analyses were performed to investigate the NASH phenotype.
RESULTS: A high-fat diet caused hepatic macrosteatosis and hepatitis, characterized by increased hepatic tumor necrosis factor alpha levels and activation of the NF-kappaB pathway in L-SACC1 but not in wild-type mice. The high-fat diet also induced necrosis and apoptosis in the livers of the L-SACC1 mice. Insulin resistance in L-SACC1 fed a high-fat diet increased the hepatic procollagen protein level, suggesting a role in the development of fibrosis.
CONCLUSIONS: A high-fat diet induces key features of human NASH in insulin-resistant L-SACC1 mice, validating this model as a tool to study the molecular mechanisms of NASH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848945      PMCID: PMC2784638          DOI: 10.1053/j.gastro.2008.08.007

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  53 in total

Review 1.  NASH--hepatic metabolism and not simply the metabolic syndrome.

Authors:  Richard M Green
Journal:  Hepatology       Date:  2003-07       Impact factor: 17.425

2.  Apolipoprotein synthesis in nonalcoholic steatohepatitis.

Authors:  Michael Charlton; Raghavakaimal Sreekumar; Deborah Rasmussen; Keith Lindor; K Sreekumaran Nair
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

3.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

4.  Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.

Authors:  Zhiping Li; Mark J Soloski; Anna Mae Diehl
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

5.  NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis.

Authors:  Aileen Dela Peña; Isabelle Leclercq; Jacqueline Field; Jacob George; Brett Jones; Geoffrey Farrell
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

6.  IKK-beta links inflammation to obesity-induced insulin resistance.

Authors:  Melek C Arkan; Andrea L Hevener; Florian R Greten; Shin Maeda; Zhi-Wei Li; Jeffrey M Long; Anthony Wynshaw-Boris; Giuseppe Poli; Jerrold Olefsky; Michael Karin
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

7.  Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression.

Authors:  David Patsouris; Janardan K Reddy; Michael Müller; Sander Kersten
Journal:  Endocrinology       Date:  2005-12-15       Impact factor: 4.736

8.  Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

Authors:  Jason M Hui; James G Kench; Shivakumar Chitturi; Archana Sud; Geoffrey C Farrell; Karen Byth; Pauline Hall; Mahbub Khan; Jacob George
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

Review 9.  Intracellular cholesterol transport.

Authors:  Raymond E Soccio; Jan L Breslow
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-05-06       Impact factor: 8.311

10.  Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes.

Authors:  Aaron P Kellogg; Tim D Wiggin; Dennis D Larkin; John M Hayes; Martin J Stevens; Rodica Pop-Busui
Journal:  Diabetes       Date:  2007-08-24       Impact factor: 9.461

View more
  22 in total

1.  Carcinoembryonic antigen-related cell adhesion molecule 2 controls energy balance and peripheral insulin action in mice.

Authors:  Garrett Heinrich; Sumona Ghosh; Anthony M Deangelis; Jill M Schroeder-Gloeckler; Payal R Patel; Tamara R Castaneda; Shane Jeffers; Abraham D Lee; Dae Young Jung; Zhiyou Zhang; Darren M Opland; Martin G Myers; Jason K Kim; Sonia M Najjar
Journal:  Gastroenterology       Date:  2010-04-08       Impact factor: 22.682

2.  Exenatide Prevents Diet-induced Hepatocellular Injury in A CEACAM1-Dependent Mechanism.

Authors:  Hilda E Ghadieh; Harrison T Muturi; Sonia M Najjar
Journal:  J Diabetes Treat       Date:  2017-12-19

3.  Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice.

Authors:  Manya Warrier; Terry D Hinds; Kelly J Ledford; Harrison A Cash; Payal R Patel; Thomas A Bowman; Lance A Stechschulte; Weidong Yong; Weinian Shou; Sonia M Najjar; Edwin R Sanchez
Journal:  Endocrinology       Date:  2010-04-28       Impact factor: 4.736

4.  Caloric restriction reverses hepatic insulin resistance and steatosis in rats with low aerobic capacity.

Authors:  Thomas A Bowman; Sadeesh K Ramakrishnan; Meenakshi Kaw; Sang Jun Lee; Payal R Patel; Varun K Golla; Raymond E Bourey; Per Magnus Haram; Lauren G Koch; Steven L Britton; Ulrik Wisløff; Abraham D Lee; Sonia M Najjar
Journal:  Endocrinology       Date:  2010-09-22       Impact factor: 4.736

5.  High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion.

Authors:  Caixia Li; Silas A Culver; Syed Quadri; Kelly L Ledford; Qusai Y Al-Share; Hilda E Ghadieh; Sonia M Najjar; Helmy M Siragy
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-09-15       Impact factor: 4.310

6.  Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis.

Authors:  Lucia Russo; Hilda E Ghadieh; Simona S Ghanem; Qusai Y Al-Share; Zachary N Smiley; Cara Gatto-Weis; Emily L Esakov; Marcia F McInerney; Garrett Heinrich; Xin Tong; Lei Yin; Sonia M Najjar
Journal:  J Lipid Res       Date:  2016-10-24       Impact factor: 5.922

Review 7.  CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).

Authors:  Sonia M Najjar; Lucia Russo
Journal:  Semin Immunopathol       Date:  2013-11-21       Impact factor: 9.623

8.  Loss of mammal-specific tectorial membrane component carcinoembryonic antigen cell adhesion molecule 16 (CEACAM16) leads to hearing impairment at low and high frequencies.

Authors:  Robert Kammerer; Lukas Rüttiger; Rainer Riesenberg; Constanze Schäuble; Rosemarie Krupar; Annegret Kamp; Kishiko Sunami; Andreas Eisenried; Martin Hennenberg; Fritz Grunert; Andreas Bress; Sebastiano Battaglia; Heinrich Schrewe; Marlies Knipper; Marlon R Schneider; Wolfgang Zimmermann
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

9.  High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.

Authors:  Rohit Kohli; Michelle Kirby; Stavra A Xanthakos; Samir Softic; Ariel E Feldstein; Vijay Saxena; Peter H Tang; Lili Miles; Michael V Miles; William F Balistreri; Stephen C Woods; Randy J Seeley
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

10.  Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α.

Authors:  Joseph S Marino; Lance A Stechschulte; David E Stec; Andrea Nestor-Kalinoski; Sydni Coleman; Terry D Hinds
Journal:  J Biol Chem       Date:  2016-10-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.